covering the full spectrum of HCT, cellular therapy and gene therapy research. This approach fosters collaboration across disciplines and translates research findings into impactful clinical ...

ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy.

As nutritionists often advocate, eating a diverse range of colorful fruits and vegetables is not just about aesthetics; it is ...

US Cellular will sell select spectrum licenses to AT&T in a $1.02 billion cash deal, continuing to monetize the spectrum not ...

After selling to T-Mobile and Verizon, US Cellular has sold another chunk of its spectrum to AT&T now. Here’s what it could mean for you.

Serve Robotics said on Thursday it would acquire Vebu, the company behind the avocado processing robot Autocado. TakeAway ...

US Cellular (USM) said Thursday it agreed to sell some of its spectrum licenses to telecommunications giant AT&T (T) for about $1.02 billion in cash. The tower operator said the deal is part of its ...

UScellular (NYSE: USM) sells spectrum licenses to AT&T for $1.018 billion, aligning with strategy to capitalize on assets.

United States Cellular said on Thursday it has agreed to sell a portion of spectrum licenses used to transmit mobile phone ...

The transaction is part of the regional wireless carrier's strategy to monetize its spectrum assets that were not part of the ...

UScellular agrees to sell spectrum assets to AT&T for $1.018B as part of strategic monetization plan, reaching deals to monetize majority of holdings.

US Cellular Corp. agreed to sell some spectrum assets to AT&T Corp. for $1.02 billion as the tower operator continues the ...